Drug Type Biological products |
Synonyms Antigen-specific EIE Cells(Shenzhen Geno-Immune Medical Institute), Autologous GI cancer antigen-specific engineered immune effector cells(Shenzhen Geno-Immune Medical Institute), Autologous gastro-intestinal cancer antigen-specific engineered immune effector cells(Shenzhen Geno-Immune Medical Institute) |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colorectal Cancer | Phase 2 | China | 01 Jul 2018 | |
Esophageal Carcinoma | Phase 2 | China | 01 Jul 2018 | |
Stomach Cancer | Phase 2 | China | 01 Jul 2018 |